Page 119 - Read Online

Oo et al. Mini-invasive Surg 2019;3:13 I http://dx.doi.org/10.20517/2574-1225.2019.02 Page 7 of 9

reconstruction. Minimally invasive approach is promising especially in experienced hands however more
data on long-term oncological results is needed.

Multimodality treatment is superior to surgery alone in locally advanced resectable GEJ tumours. The
advantages of neoadjuvant or perioperative treatment are downstaging of tumour, reducing the risk of
recurrence, improving rates of R0 resection and improving outcomes after complete resection. At present,
there is no global consensus on the optimal multimodality management of GEJ tumours. Further studies
are needed to explore the optimal treatment strategy including surgical approach, sequence and regimen of
multimodality management .

DECLARATIONS
Authors’ contributions
Oo AM and Ahmed S contributed equally to literature search and writing of manuscript.

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
The authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2019.

REFERENCES
1. Chai J, Jamal MM. Esophageal malignancy: a growing concern. World J Gastroenterol 2012;18:6521-6.
2. Lerut T. Carcinoma of the esophagus and gastro-esophageal junction. 2001.
3. Wu AW, Ji JF. Adenocarcinoma of esophagogastric junction requires a clearer definition. Transl Gastrointest Cancer 2013;2:5-9.
4. Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998;85:1457-9.
5. Wittekind Ch, Sobin LH, Gospodarowicz MK. TNM classification of malignant tumours. 7th ed. Blackwell Publishing Ltd; 2009.
6. Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, et al. AJCC Cancer Staging Manual. 8th ed. Springer; 2017.
7. Kshivets O. Cardioesophageal cancer: best treatment strategies. Open Cardiovasc Thorac Surg J 2009;2:21-32.
8. Strong VE, Song KY, Park CH, Jacks LM, Gonen M, et al. Comparison of gastric cancer survival following R0 resection in the United
States and Korea using an internationally validated nomogram. Ann Surg 2010;251:640-6.
9. Wu AW, Ji JF, Yang H, Li YN, Li SX, et al. Long-term outcome of a large series of gastric cancer patients in China, Chinese J Cancer
Res 2010;22:167-75.
10. Cellini F, Morganti AG, Di Matteo FM, Mattiucci GC, Valentini V. Clinical management of gastroesophageal junction tumors: past and
recent evidences for the role of radiotherapy in the multidisciplinary approach. Radiat Oncol 2014;9:45.
11. Ekström AM, Signorello LB, Hansson LE, Bergström R, Lindgren A, et al. Evaluating gastric cancer misclassification: a potential
explanation for the rise in cardia cancer incidence. J Natl Cancer Inst 1999;91:786-90.
12. Kauer WK, Peters JH, DeMeester TR, Feussner H, Ireland AP, et al. Composition and concentration of bile acid reflux into the
esophagus of patients with gastroesophageal reflux disease. Surgery 1997;122:874-81.
13. Miwa K, Sahara H, Segawa M, Kinami S, Sato T, et al. Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma
in rats. Int J Cancer 1996;67:269-74.
14. T. Miyashita, T. Ohta, T. Fujimura, I. Ninomiya, S. Fushida, et al. Duodenal juice stimulates oesophageal stem cells to induce Barrett’s
oesophagus and oesophageal adenocarcinoma in rats. Oncol Rep 2006;1469-75.